# Opioid-Induced Swallowing Dysfunction - The Impact of Bolus Volume

> **NCT03283020** · PHASE4 · UNKNOWN · sponsor: **Region Örebro County** · enrollment: 20 (estimated)

## Conditions studied

- Pharyngeal Dysfunction
- Pharyngeal Swallowing

## Interventions

- **DRUG:** RemifentanilMNTX
- **DRUG:** PlaceboMNTX

## Key facts

- **NCT ID:** NCT03283020
- **Lead sponsor:** Region Örebro County
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2017-11-11
- **Primary completion:** 2018-04-01
- **Final completion:** 2018-04-01
- **Target enrollment:** 20 (ESTIMATED)
- **Last updated:** 2017-12-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03283020

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03283020, "Opioid-Induced Swallowing Dysfunction - The Impact of Bolus Volume". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT03283020. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*